Biohit Oyj Class B (EUR)
BIOBV
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.36 | 2.44
52-Wk Range- | -
Last Close2.44
Mkt Cap (m)36.71
Dividend yield-
ISINFI0009005482
Volume11,030.00
Exchange VenueHEL

Company Profile

Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products and systems for diagnostic analysis for the use of research institutions, health care and industry.

Key Information
Price/Earning-
Price/Book2.52
Price/Sales3.64
P/CF441.12
Rev Growth (3 year avg)7.05
EPS Growth (3 year avg)-
Operating Margin % -14.04
Net Margin %-14.10
Return on Equity-9.30
Debt/Equity0.02

Documents

Prospectus
en 07/09/2018
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.biohithealthcare.com

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)4.366.058.208.989.9310.05
Operating Income (m)-4.51-3.56-3.17-1.63-1.96-1.41
Net Income (m)-1.16-2.92-3.306.14-2.14-1.42
Basic EPS-0.32-0.20-0.220.42-0.14-0.09
Avg. Diluted Shares Outstanding (m)14.5214.7015.0514.9415.0215.01
Balance Sheet
EUR201420152016201720182019
Current Assets (m)12.018.8810.5911.3512.2313.21
Non Current Assets (m)2.502.852.407.545.664.16
Total Assets (m)14.5111.7312.9918.9017.8917.37
Current Liabilities (m)1.631.241.821.281.572.38
Total Liabilities (m)------
Total Equity (m)12.6810.3110.7517.2415.8914.58
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)-3.44-3.15-2.46-0.94-0.090.08
Capital Expenditure (m)-0.40-0.22-0.09-0.17-0.02-0.05
Figures are quoted in EUR unless stated otherwise
-
No change
2.44
Last Price